Nordic Bioproducts Group

Nordic Bioproducts Group shortlisted as CPHI Pharma Awards 2024 Finalist for sustainability

This recognition highlights the breakthrough of the company’s Microcrystalline Cellulose (MCC) production at their new production facility, powered by the patented AaltoCell™ technology. 9 October 2024 – Espoo, Finland – Nordic Bioproducts Group (NBG) has announced that it was selected as one of the finalists at the CPHI Pharma Awards 2024 in the sustainability category. The recognition came...

Nordic Bioproducts Group Receives Pharmaceutical Industry’s EXCiPACT Certification for MCC Production at Lappeenranta Facility

The Finnish company’s new factory has received the prestigious certification after being thoroughly audited by a recognized international entity. Nordic Bioproducts Group’s product offers the perfect solution for the pharmaceutical industry, combining quality and sustainability. 26 June 2024 - Espoo, Finland - Nordic Bioproducts Group today announces that its new manufacturing factory in Lappeenranta, Finland, has received...
Nordic Bioproducts Group, Oy Tietotie 1, 02150 Espoo, Finland

358 50 505 94 64